« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2
, Pages 356-364
, 1 October 2008
Quality of Life and Survival Outcome for Patients With Nasopharyngeal Carcinoma Receiving Three-Dimensional Conformal Radiotherapy vs. Intensity-Modulated Radiotherapy—A Longitudinal Study
References
- . Radiotherapy for nasopharyngeal carcinoma—transition from two-dimensional to three-dimensional methods. Radiother Oncol. 2004;73:163–172
- Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol. 2005;75:204–209
- Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol. 2001;61:275–280
- Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol. 2005;74:251–258
- Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study. Head Neck. 2006;28:712–722
- Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative scintigraphy and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:454–461
- Intensity-modulated or conformal radiotherapy improves quality of life of patients with nasopharyngeal carcinoma—comparisons of four radiotherapy techniques. Cancer. 2007;109:311–321
- Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000;48:711–722
- Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329–337
- Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:638–647
- Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of RT. Int J Radiat Oncol Biol Phys. 2001;50:961–969
- Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: The appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. Radiother Oncol. 2005;77:53–57
- . Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol. 1992;31:311–321
- The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
- Quality of life in head and neck cancer patients: Validation of the EORTC H&N35. J Clin Oncol. 1999;17:1008–1019
- EORTC QLQ-C30 scoring manual. 2nd edition. Brussels, Belgium: EORTC Data Center; 1999;
- . The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5:555–567
- Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–144
- Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer. 2004;101:1584–1593
- Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22
- Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57–62
- Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2001;49:1229–1234
- Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys. 2002;53:959–968
- . Nasopharyngeal carcinoma. Lancet. 2005;365:2041–2054
- Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–4879
- . Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol. 2000;12:215–220
- A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope. 1998;108:747–759
- A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck. 1999;21:291–296
- Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110:98–106
- A prospective study of quality of life in head and neck cancer patients part II: Longitudinal data. Laryngoscope. 2001;111:1440–1452
- . Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms. Br J Cancer. 2001;84:149–156
- Phase III quality of life study: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer—RTOG 97–09. Int J Radiat Oncol Biol Phys. 2003;56:832–836
- Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005;61:1403–1407
- . Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol. 2002;41:229–237
- . Integrating response shift into health-related quality of life research: a theoretical model. Social Sci Med. 1999;48:1507–1515
- Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys. 2005;63:1347–1353
Supported by the grant NSC 90-2320-B-182A-006 from the National Science Council, Taiwan; and CMRP610 from the Chang Gung Memorial Hospital, Taiwan.
Conflict of interest: none.
PII: S0360-3016(08)00052-7
doi: 10.1016/j.ijrobp.2007.12.054
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2
, Pages 356-364
, 1 October 2008
